- Home
- BNL vs HCM Comparison
BNL vs HCM Comparison
Compare BNL & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNL
- HCM
- Stock Information
- Founded
- BNL 2007
- HCM 2000
- Country
- BNL United States
- HCM Hong Kong
- Employees
- BNL N/A
- HCM N/A
- Industry
- BNL Real Estate Investment Trusts
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- BNL Real Estate
- HCM Health Care
- Exchange
- BNL Nasdaq
- HCM Nasdaq
- Market Cap
- BNL 3.0B
- HCM 2.5B
- IPO Year
- BNL 2020
- HCM N/A
- Fundamental
- Price
- BNL $15.94
- HCM $14.61
- Analyst Decision
- BNL Hold
- HCM Hold
- Analyst Count
- BNL 6
- HCM 1
- Target Price
- BNL $18.60
- HCM $19.00
- AVG Volume (30 Days)
- BNL 1.5M
- HCM 122.7K
- Earning Date
- BNL 04-30-2025
- HCM 03-19-2025
- Dividend Yield
- BNL 7.29%
- HCM N/A
- EPS Growth
- BNL 3.57
- HCM N/A
- EPS
- BNL 0.86
- HCM 0.04
- Revenue
- BNL $431,800,000.00
- HCM $630,201,000.00
- Revenue This Year
- BNL $5.31
- HCM $28.98
- Revenue Next Year
- BNL $4.57
- HCM $20.41
- P/E Ratio
- BNL $18.53
- HCM $71.43
- Revenue Growth
- BNL N/A
- HCM N/A
- 52 Week Low
- BNL $13.96
- HCM $11.51
- 52 Week High
- BNL $19.15
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- BNL 47.08
- HCM 50.17
- Support Level
- BNL $15.73
- HCM $15.00
- Resistance Level
- BNL $16.36
- HCM $15.79
- Average True Range (ATR)
- BNL 0.60
- HCM 0.72
- MACD
- BNL 0.05
- HCM 0.20
- Stochastic Oscillator
- BNL 82.29
- HCM 70.97
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.